View in EDS HTML Full Text PDF Full Text

Sustained Complete Response to Brigatinib in a Young Patient With ALK-Positive NSCLC Harboring I1171N Mutation Post-Alectinib Resistance.

Saved in:
Bibliographic Details
Title: Sustained Complete Response to Brigatinib in a Young Patient With ALK-Positive NSCLC Harboring I1171N Mutation Post-Alectinib Resistance.
Authors: Kapoor A; Department of Medical Oncology, Homi Bhabha Cancer Hospital and Mahamana Pandit Madan Mohan Malaviya Cancer Centre, Tata Memorial Centre, Homi Bhabha National Institute, Varanasi, India, hbni.ac.in., Singh AK; Department of Medical Oncology, Paras Hospital, Kanpur, India., Chaudhary M; Department of Medical Oncology, Homi Bhabha Cancer Hospital and Mahamana Pandit Madan Mohan Malaviya Cancer Centre, Tata Memorial Centre, Homi Bhabha National Institute, Varanasi, India, hbni.ac.in., Gupta A; Department of Medical Oncology, Homi Bhabha Cancer Hospital and Mahamana Pandit Madan Mohan Malaviya Cancer Centre, Tata Memorial Centre, Homi Bhabha National Institute, Varanasi, India, hbni.ac.in., Sansar B; Department of Medical Oncology, Homi Bhabha Cancer Hospital and Mahamana Pandit Madan Mohan Malaviya Cancer Centre, Tata Memorial Centre, Homi Bhabha National Institute, Varanasi, India, hbni.ac.in., Mishra BK; Department of Medical Oncology, Homi Bhabha Cancer Hospital and Mahamana Pandit Madan Mohan Malaviya Cancer Centre, Tata Memorial Centre, Homi Bhabha National Institute, Varanasi, India, hbni.ac.in., Patne S; Department of Pathology, Homi Bhabha Cancer Hospital and Mahamana Pandit Madan Mohan Malaviya Cancer Centre, Tata Memorial Centre, Homi Bhabha National Institute, Varanasi, India, hbni.ac.in., Suresh A; Department of Nuclear Medicine & Molecular Imaging, Homi Bhabha Cancer Hospital and Mahamana Pandit Madan Mohan Malaviya Cancer Centre, Tata Memorial Centre, Homi Bhabha National Institute, Varanasi, India, hbni.ac.in.
Source: Case reports in oncological medicine [Case Rep Oncol Med] 2026 Feb 19; Vol. 2026, pp. 7372418. Date of Electronic Publication: 2026 Feb 19 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 101581035 Publication Model: eCollection Cited Medium: Print ISSN: 2090-6706 (Print) NLM ISO Abbreviation: Case Rep Oncol Med Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41726081
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Sustained Complete Response to Brigatinib in a Young Patient With ALK-Positive NSCLC Harboring I1171N Mutation Post-Alectinib Resistance.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Kapoor+A%22">Kapoor A</searchLink>; Department of Medical Oncology, Homi Bhabha Cancer Hospital and Mahamana Pandit Madan Mohan Malaviya Cancer Centre, Tata Memorial Centre, Homi Bhabha National Institute, Varanasi, India, hbni.ac.in.<br /><searchLink fieldCode="AU" term="%22Singh+AK%22">Singh AK</searchLink>; Department of Medical Oncology, Paras Hospital, Kanpur, India.<br /><searchLink fieldCode="AU" term="%22Chaudhary+M%22">Chaudhary M</searchLink>; Department of Medical Oncology, Homi Bhabha Cancer Hospital and Mahamana Pandit Madan Mohan Malaviya Cancer Centre, Tata Memorial Centre, Homi Bhabha National Institute, Varanasi, India, hbni.ac.in.<br /><searchLink fieldCode="AU" term="%22Gupta+A%22">Gupta A</searchLink>; Department of Medical Oncology, Homi Bhabha Cancer Hospital and Mahamana Pandit Madan Mohan Malaviya Cancer Centre, Tata Memorial Centre, Homi Bhabha National Institute, Varanasi, India, hbni.ac.in.<br /><searchLink fieldCode="AU" term="%22Sansar+B%22">Sansar B</searchLink>; Department of Medical Oncology, Homi Bhabha Cancer Hospital and Mahamana Pandit Madan Mohan Malaviya Cancer Centre, Tata Memorial Centre, Homi Bhabha National Institute, Varanasi, India, hbni.ac.in.<br /><searchLink fieldCode="AU" term="%22Mishra+BK%22">Mishra BK</searchLink>; Department of Medical Oncology, Homi Bhabha Cancer Hospital and Mahamana Pandit Madan Mohan Malaviya Cancer Centre, Tata Memorial Centre, Homi Bhabha National Institute, Varanasi, India, hbni.ac.in.<br /><searchLink fieldCode="AU" term="%22Patne+S%22">Patne S</searchLink>; Department of Pathology, Homi Bhabha Cancer Hospital and Mahamana Pandit Madan Mohan Malaviya Cancer Centre, Tata Memorial Centre, Homi Bhabha National Institute, Varanasi, India, hbni.ac.in.<br /><searchLink fieldCode="AU" term="%22Suresh+A%22">Suresh A</searchLink>; Department of Nuclear Medicine & Molecular Imaging, Homi Bhabha Cancer Hospital and Mahamana Pandit Madan Mohan Malaviya Cancer Centre, Tata Memorial Centre, Homi Bhabha National Institute, Varanasi, India, hbni.ac.in.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101581035%22">Case reports in oncological medicine</searchLink> [Case Rep Oncol Med] 2026 Feb 19; Vol. 2026, pp. 7372418. <i>Date of Electronic Publication: </i>2026 Feb 19 (<i>Print Publication: </i>2026).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101581035 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2090-6706 (Print) <i>NLM ISO Abbreviation: </i>Case Rep Oncol Med <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41726081
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1155/crom/7372418
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 7372418
    Titles:
      – TitleFull: Sustained Complete Response to Brigatinib in a Young Patient With ALK-Positive NSCLC Harboring I1171N Mutation Post-Alectinib Resistance.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Kapoor A
      – PersonEntity:
          Name:
            NameFull: Singh AK
      – PersonEntity:
          Name:
            NameFull: Chaudhary M
      – PersonEntity:
          Name:
            NameFull: Gupta A
      – PersonEntity:
          Name:
            NameFull: Sansar B
      – PersonEntity:
          Name:
            NameFull: Mishra BK
      – PersonEntity:
          Name:
            NameFull: Patne S
      – PersonEntity:
          Name:
            NameFull: Suresh A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 19
              M: 02
              Text: 2026 Feb 19
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 2090-6706
          Numbering:
            – Type: volume
              Value: 2026
          Titles:
            – TitleFull: Case reports in oncological medicine
              Type: main
ResultId 1